ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

July 19, 2002

Marie Lombardi NCAB Member, Dies; HHS Holding Up Board Appointments

April 23, 1982

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Final Issues Of 1982

December 10, 1982

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

Women’s Health Trial RFPs Issued; Three Clinical Centers Sought

April 12, 1991